Sees Q4 revenue $420M-$440M, consensus $456.2M.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IART:
- Integra LifeSciences reports Q3 adjusted EPS 54c, consensus 43c
- Integra LifeSciences narrows 2025 adj EPS view to $2.19-$2.24 from $2.19-$2.29
- IART Upcoming Earnings Report: What to Expect?
- Integra LifeSciences’ Innovative Approach to Ulcer Treatment: A Study Update
- Integra LifeSciences Advances with MIRROR Registry Study on Hematoma Evacuation